China Resources Double-Crane Pharmaceutical Co.,Ltd.

China Resources Double-Crane Pharmaceutical Co.,Ltd.

Share · CNE000000Q94 (XSHG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of China Resources Double-Crane Pharmaceutical Co.,Ltd.
No Price
Closing Price XSHG 29.04.2026: 17,96 CNY
29.04.2026 07:00
Current Prices from China Resources Double-Crane Pharmaceutical Co.,Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
600062.SS
CNY
29.04.2026 07:00
17,96 CNY
0,08 CNY
+0,45 %
Share Float & Liquidity
Free Float 38,07 %
Shares Float 395,44 M
Shares Outstanding 1,04 B
Company Profile for China Resources Double-Crane Pharmaceutical Co.,Ltd. Share
China Resources Double-Crane Pharmaceutical Co.,Ltd., together with its subsidiaries, operates as a pharmaceutical company in the People's Republic of China. The company offers soft bag, plastic and glass bottle, inner sealed polypropylene, and polypropylene blend bag infusion products; levofloxacin methylate, ambroxol hydrochloride glucose, fructose, invert sugar, hydroxyethyl starch, sodium chloride injection products, etc.; and peritoneal dialysate, hemodialysis dialysate, etc. It also provides compound reserpine triamterene tablets, pitavastatin calcium tablets, telmisartan capsules, suppository capsules, banidipine hydrochloric acid sustained-release capsules, edaravone, and other products to treat cardiovascular and cerebrovascular diseases. In addition, the company offers products for endocrinology; and pediatric compound amino acid injection, and other drugs to treat pediatrics. Further, it provides nutritional drugs, including vitamin E and C; and anti-infective drugs. The company is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. is a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Company Data

Name China Resources Double-Crane Pharmaceutical Co.,Ltd.
Company China Resources Double-Crane Pharmaceutical Co.,Ltd.
Website https://www.dcpc.com
Primary Exchange XSHG SSE
ISIN CNE000000Q94
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Qian Zhao
Market Capitalization 19 Mrd.
Country China
Currency CNY
Employees 13,4 T
Address No. 1, Lize East 2nd Road, 100102 Beijing
IPO Date 1997-05-22
Dividends from 'China Resources Double-Crane Pharmaceutical Co.,Ltd.'
Ex-Date Dividend per Share
28.10.2025 0,10 CNY
11.07.2025 0,37 CNY
08.11.2024 0,10 CNY
15.07.2024 0,26 CNY
13.07.2023 0,29 CNY
28.09.2022 0,29 CNY
16.06.2022 0,48 CNY
13.07.2021 0,29 CNY
17.07.2020 0,30 CNY
19.07.2019 0,28 CNY

Stock Splits

Date Split
16.08.2018 6:5
17.07.2017 6:5
16.07.2009 6:5
13.05.2002 13:10
27.04.2000 13:10
17.03.1999 3:2

Ticker Symbols

Name Symbol
SSE 600062.SS
More Shares
Investors who hold China Resources Double-Crane Pharmaceutical Co.,Ltd. also have the following shares in their portfolio:
Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd. Share
QUALCOMM INC
QUALCOMM INC Share